AI assistant
Sending…
VIVOZON PHARMACEUTICAL CO., LTD. — Capital/Financing Update 2020
Jan 17, 2020
15941_rns_2020-01-17_52599cca-acbc-472c-bc72-7ae7e588a751.html
Capital/Financing Update
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
루미마이크로/증권 발행결과(자율공시)/(2020.01.17)증권 발행결과(자율공시)(제13회차 CB)
증권 발행결과(자율공시)
| 1. 증권의 종류 | 제13회무기명식 이권부 무보증 사모 전환사채 | |
| 2. 발행방법 | 국내사모 전환사채 발행 | |
| 3. 발행내역 | 발행예정주식수(주) | - |
| 발행예정금액(원) | 10,000,000,000 | |
| 발행결정 최초 이사회결의일 | 2019-11-18 | |
| 실제발행주식수(주) | - | |
| 실제발행금액(원) | 10,000,000,000 | |
| 납입일 | 2020-01-17 | |
| 4. 상장예정 여부 | 아니오 | |
| 5. 기타 투자판단에 참고할 사항 | - | |
| ※관련공시 | 2020-01-09 전환사채권발행결정(제13회) |
More from VIVOZON PHARMACEUTICAL CO., LTD.
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 30
Director's Dealing
2026
Apr 15
Director's Dealing
2026
Apr 15
Transaction in Own Shares
2026
Apr 15
Transaction in Own Shares
2026
Apr 10
Major Shareholding Notification
2026
Apr 9
Director's Dealing
2026
Apr 6
Director's Dealing
2026
Apr 3
Board/Management Information
2026
Apr 1